KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Free Cash Flow (2018 - 2025)

Vir Biotechnology's Free Cash Flow history spans 8 years, with the latest figure at -$26.2 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 70.74% to -$26.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$396.6 million, a 12.57% increase, with the full-year FY2025 number at -$396.6 million, up 12.57% from a year prior.
  • Free Cash Flow hit -$26.2 million in Q4 2025 for Vir Biotechnology, up from -$167.9 million in the prior quarter.
  • Over the last five years, Free Cash Flow for VIR hit a ceiling of $939.5 million in Q2 2022 and a floor of -$398.7 million in Q2 2023.
  • Historically, Free Cash Flow has averaged -$6.2 million across 5 years, with a median of -$89.8 million in 2021.
  • Biggest five-year swings in Free Cash Flow: surged 1178.84% in 2021 and later crashed 585.38% in 2023.
  • Tracing VIR's Free Cash Flow over 5 years: stood at -$9.9 million in 2021, then surged by 327.09% to $22.6 million in 2022, then crashed by 585.38% to -$109.5 million in 2023, then rose by 18.12% to -$89.6 million in 2024, then skyrocketed by 70.74% to -$26.2 million in 2025.
  • Business Quant data shows Free Cash Flow for VIR at -$26.2 million in Q4 2025, -$167.9 million in Q3 2025, and -$122.8 million in Q2 2025.